Department of Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.
Department of Cardiovascular and Thoracic Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.
Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):529-538. doi: 10.1158/1055-9965.EPI-20-0950. Epub 2020 Dec 10.
Race/ethnicity-related differences in rates of cancer surgery and cancer mortality have been observed for gastrointestinal (GI) cancers. This study aims to estimate the extent to which differences in receipt of surgery explain racial/ethnic disparities in cancer survival.
The National Cancer Database was used to obtain data for patients diagnosed with stage I-III mid-esophageal, distal esophagus/gastric cardia (DEGC), noncardia gastric, pancreatic, and colorectal cancer in years 2004-2015. Mediation analysis was used to identify variables influencing the relationship between race/ethnicity and mortality, including surgery.
A total of 600,063 patients were included in the study: 3.5% mid-esophageal, 12.4% DEGC, 4.9% noncardia gastric, 17.0% pancreatic, 40.1% colon, and 22.0% rectal cancers. The operative rates for Black patients were low relative to White patients, with absolute differences of 21.0%, 19.9%, 2.3%, 8.3%, 1.6%, and 7.7%. Adjustment for age, stage, and comorbidities revealed even lower odds of receiving surgery for Black patients compared with White patients. The observed HRs for Black patients compared with White patients ranged from 1.01 to 1.42. Mediation analysis showed that receipt of surgery and socioeconomic factors had greatest influence on the survival disparity.
The results of this study indicate that Black patients appear to be undertreated compared with White patients for GI cancers. The disproportionately low operative rates contribute to the known survival disparity between Black and White patients.
Interventions to reduce barriers to surgery for Black patients should be promoted to reduce disparities in GI cancer outcomes..
在胃肠道(GI)癌症中,已经观察到与种族/族裔相关的癌症手术率和癌症死亡率存在差异。本研究旨在估计手术接受程度差异在多大程度上解释了癌症生存种族/族裔差异。
使用国家癌症数据库获取 2004 年至 2015 年期间诊断为 I-III 期食管中段、食管下段/胃贲门(DEGC)、非贲门胃、胰腺和结直肠癌的患者数据。中介分析用于确定影响种族/族裔与死亡率之间关系的变量,包括手术。
共有 600,063 名患者纳入研究:3.5%为食管中段癌,12.4%为 DEGC,4.9%为非贲门胃癌,17.0%为胰腺癌,40.1%为结肠癌,22.0%为直肠癌。黑人患者的手术率相对白人患者较低,绝对差异为 21.0%、19.9%、2.3%、8.3%、1.6%和 7.7%。调整年龄、分期和合并症后,黑人患者接受手术的可能性仍低于白人患者。与白人患者相比,黑人患者的观察到的 HR 范围为 1.01 至 1.42。中介分析表明,手术接受情况和社会经济因素对生存差异的影响最大。
本研究结果表明,与白人患者相比,黑人患者似乎在 GI 癌症治疗方面受到歧视。手术率的不成比例降低导致了黑人和白人患者之间已知的生存差异。
应促进减少黑人患者手术障碍的干预措施,以减少 GI 癌症结果的差异。